Biosergen AB Financial Overview
Biosergen AB's market cap is currently €100.03M. The company's EPS TTM is kr-5.182; its P/E ratio is -2.97; Biosergen AB is scheduled to report earnings on November 19, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
